Form D · Other Health Care
Otello Medical, Inc.
Laguna Hills, CA · CIK 0001749722
Offering snapshot reported Aug 10, 2018 · SEC filing
- Reported sold
- $1.64M Offering amount: $1.64M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 26, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 10, 2018 | Initial | $1,640,000 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-318935
Of this amount, $1,600,000 relates to the sale of 800,000 shares of the Issuer's Series A Preferred Stock. The remaining $40,000 (estimated for fee purposes only) relates to the sale of 200,000 shares of the Issuer's Common Stock.
Source: Form D, filed Aug 10, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Olav B. Bergheim | Director, Executive |
| Michael J. Griffith | Director |
| Hugh A. Neuharth | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
26051 Merit Circle Suite 102
Laguna Hills, CA, 92653
Laguna Hills, CA, 92653